| Dr Stephanie Boyd Henson, MD | |
|
1801 Fairfield Ave, Suite 201, Shreveport, LA 71101-4443 | |
| (318) 848-2810 | |
| (318) 848-2815 |
| Full Name | Dr Stephanie Boyd Henson |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 1801 Fairfield Ave, Shreveport, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023239373 | NPI | - | NPPES |
| 1493791 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 022552 (Louisiana) | Primary |
| Entity Name | Louisiana Department Of Health - Office Of Public Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144372343 PECOS PAC ID: 5890700694 Enrollment ID: O20140815000393 |
News Archive
The American Society of Nephrology strongly recommends that all adults undergo routine screening for chronic kidney disease (CKD), the 8th leading cause of death in the U.S. This contradicts screening guidelines recently released by the American College of Physicians (ACP).
Seattle Children's today announced the opening of patient enrollment for the first clinical research trial of the drug Tumor Paint BLZ-100, which is designed to improve surgical outcomes in children with brain tumors – the most common solid tumor cancer in kids.
Women's health is increasingly undervalued in conflicts over reproductive rights, including clashes based on moral objections under so-called conscience clauses, a new study by a University of Illinois legal expert found.
Many breast cancer patients are treated with a drug called tamoxifen. The substance blocks the effect of estrogen and thus suppresses the growth signals of this hormone in cancer cells. When resistance to the drug develops, tumor cells change their growth program: They change their behavior and shape, become more mobile and also adopt the ability to invade surrounding tissue. Scientists working with PD (Associate Professor) Dr. Stefan Wiemann of the German Cancer Research Center (DKFZ) have now also observed these changes in tamoxifen resistant breast cancer cells.
Immodulon recently met with some of the world's most renowned oncologists to present their forthcoming trials for immunotherapy treatment, IMM-101.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephanie Boyd Henson, MD 1801 Fairfield Ave, Suite 201, Shreveport, LA 71101-4443 Ph: (318) 848-2810 | Dr Stephanie Boyd Henson, MD 1801 Fairfield Ave, Suite 201, Shreveport, LA 71101-4443 Ph: (318) 848-2810 |
News Archive
The American Society of Nephrology strongly recommends that all adults undergo routine screening for chronic kidney disease (CKD), the 8th leading cause of death in the U.S. This contradicts screening guidelines recently released by the American College of Physicians (ACP).
Seattle Children's today announced the opening of patient enrollment for the first clinical research trial of the drug Tumor Paint BLZ-100, which is designed to improve surgical outcomes in children with brain tumors – the most common solid tumor cancer in kids.
Women's health is increasingly undervalued in conflicts over reproductive rights, including clashes based on moral objections under so-called conscience clauses, a new study by a University of Illinois legal expert found.
Many breast cancer patients are treated with a drug called tamoxifen. The substance blocks the effect of estrogen and thus suppresses the growth signals of this hormone in cancer cells. When resistance to the drug develops, tumor cells change their growth program: They change their behavior and shape, become more mobile and also adopt the ability to invade surrounding tissue. Scientists working with PD (Associate Professor) Dr. Stefan Wiemann of the German Cancer Research Center (DKFZ) have now also observed these changes in tamoxifen resistant breast cancer cells.
Immodulon recently met with some of the world's most renowned oncologists to present their forthcoming trials for immunotherapy treatment, IMM-101.
› Verified 2 days ago
Shaheena Anene, Pediatrics Medicare: Medicare Enrolled Practice Location: 1541 Kings Hwy, Shreveport, LA 71103 Phone: 318-626-0000 | |
Uday Kumar Chalwadi, Pediatrics Medicare: Medicare Enrolled Practice Location: 1541 Kings Hwy, Shreveport, LA 71103 Phone: 318-626-0000 | |
Lea Bonifacio Penales, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2520 Bert Kouns Loop, Suite 215, Shreveport, LA 71118 Phone: 318-212-5970 Fax: 318-212-5975 | |
Marco Quispe Leveau, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1501 Kings Hwy, Department Of Medicine, Shreveport, LA 71103 Phone: 318-675-5000 | |
Amanda Bradshaw Raney, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7045 Youree Dr, Shreveport, LA 71105 Phone: 318-798-3763 Fax: 318-797-0645 | |
Martha M Whyte, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1 Saint Mary Pl, Shreveport, LA 71101 Phone: 318-227-4658 Fax: 318-424-6606 |